Potential Class Action Against Capricor: Important Deadline Approaches for Investors Seeking Justice

Investors Alert: Capricor' s Class Action Lawsuit Deadline Approaches

As the September 15, 2025 deadline for potential lead plaintiffs in a class action lawsuit against Capricor Therapeutics, Inc. approaches, investors are urged to take immediate action. Faruqi & Faruqi, LLP, a prominent securities law firm, is investigating potential claims on behalf of shareholders who have suffered losses due to the company's alleged misconduct.

Background on Capricor

Capricor Therapeutics (NASDAQ: CAPR) has been under scrutiny following claims that it misled investors regarding its lead cell therapy candidate, deramiocel. This treatment is intended for addressing cardiomyopathy associated with Duchenne muscular dystrophy (DMD). The allegations suggest that Capricor and its executives failed to disclose critical information that could materially affect investors' decisions, particularly around the company's ability to obtain a Biologics License Application (BLA) from the U.S. Food and Drug Administration (FDA).

On July 11, 2025, following a disappointing announcement from the FDA, Capricor's stock price plummeted from $11.40 to $7.64. This decline was attributed to the FDA issuing a Complete Response Letter, indicating that the company did not meet necessary criteria to demonstrate the treatment's effectiveness and that additional clinical data was needed. The company's purportedly misleading statements before this announcement may warrant legal action, and affected shareholders are now looking at their legal options.

The Class Action Lawsuit

The class action lawsuit aims to hold Capricor accountable for its actions and secure compensation for shareholders who purchased stock between October 9, 2024, and July 10, 2025. Potential lead plaintiffs—the individuals with the most substantial financial stakes in this case—need to take deliberate steps to assert their rights under securities law. They may choose to remain anonymous and let an attorney manage their participation in the lawsuit or step forward to take a more active role.

James (Josh) Wilson, a Senior Partner at Faruqi & Faruqi, has stated that those who invested in Capricor during the specified period and suffered losses should reach out directly to discuss their options. The firm's extensive experience in securities litigation can offer affected investors a pathway to potentially reclaim losses incurred due to Capricor's alleged failures.

Next Steps for Investors

If you believe you’ve been affected by Capricor's actions, now is the time to act. Contact Faruqi & Faruqi directly at 877-247-4292 or visit their website for more information. Engaging with the firm not only provides clarity on your circumstances, but it also gives you access to dedicated legal resources that can inform your course of action.

Investors who have information relating to Capricor's handling of its securities are also encouraged to share their insights with the law firm, as this could prove beneficial in moving the case forward.

In conclusion, as the September deadline looms, it is crucial for Capricor investors to understand their rights and the options available to them. With the potential for significant financial implications, timely action could prove instrumental in securing justice and compensation for losses incurred.